Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.

CES 2025: Cardiologist check-ups, AI-powered smart mirrors coming to heart patients’ homes
Healthcare companies from all over the world are showing off their newest cardiovascular offerings at CES 2025 in Las Vegas.
Semaglutide linked to ‘significant and consistent’ benefits for heart bypass surgery patients
The popular GLP-1 receptor agonist appears to help limit adverse events and new-onset diabetes in patients with a history of CABG. Researchers shared the full study in the Journal of the American College of Cardiology.
The best diets for heart health: DASH diet surpasses Mediterranean, MIND, vegan and flexitarian options
Experts say the DASH diet, designed to lower blood pressure and improve heart health, is fairly flexible and associated with several key benefits.
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders
The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.
Merck spends up to $2B to license new weight loss drug with potential heart benefits
Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.

4 new medications and technologies that could transform cardiology in 2022

The FDA has already approved one of the medications, with a decision on another expected by the end of April.

February 18, 2022

AstraZeneca COVID-19 vaccine slightly increases risk of blood clots

Researchers emphasized that the benefits of the vaccine still far outweigh the risks.

February 17, 2022

Unreliable? 76% of world’s blood pressure monitors have not been validated

Researchers examined data on more than 3,400 BP devices used all over the world. A significant majority of them were never clinically validated for accuracy.

February 17, 2022

Risk of recurrent stroke 48% higher among young marijuana users

Marijuana use can be especially harmful to young adults with a history of stroke or TIA, researchers explained.

February 11, 2022

Heart drug trimetazidine at center of Olympics controversy surrounding figure skater Kamila Valieva

Trimetazidine, typically prescribed for treating angina, is associated with increasing blood flow and improving endurance.

February 11, 2022

The Corvia Atrial Shunt is designed to address elevated left atrial pressure (LAP) heart failure patients.

Implantable atrial shunt therapy trial identifies treatable HFpEF patients

The REDUCE LAP-HF II study identified heart failure patients who may benefit from receiving a new transcatheter implant manufactured by Corvia Medical.

February 9, 2022

Too much Tylenol? Daily acetaminophen use may be bad for hypertension patients

Daily acetaminophen use was associated with a “significant increase” in daytime systolic and diastolic blood pressure.

February 9, 2022

Chinese herbal formula treats mild hypertension as well as prescription drug

Songling Xuemaikang capsules compare favorably with losartan, potentially providing specialists with a new treatment option.

February 3, 2022

Heart Health

CES 2025: Cardiologist check-ups, AI-powered smart mirrors coming to heart patients’ homes

Semaglutide linked to ‘significant and consistent’ benefits for heart bypass surgery patients

The best diets for heart health: DASH diet surpasses Mediterranean, MIND, vegan and flexitarian options

FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

Merck spends up to $2B to license new weight loss drug with potential heart benefits